Sunday, August 25, 2019

The dangerous cocktail of substandard drugs and poor regulatory oversight in India

The dangerous cocktail of substandard drugs and poor regulatory oversight in India WHO estimates that one in ten medical products in low-and-middle-income countries is substandard or falsified. This includes India

from Moneycontrol Business News https://ift.tt/2ZA6pch

No comments:

Post a Comment

US equities end lower as valuation concerns creep in

U.S. stocks closed lower on Wednesday as investors took profits amid concerns about high valuations flagged by Fed Chair Powell. The market ...